Ralph Kern

Ralph Kern

Company: BrainStorm Cell Therapeutics

Job title: President & Chief Medical Officer

Seminars:

Chair Led Q&A 10:25 am

Read more

day: Day One

Opening Presentation: Treating Alzheimer’s Disease as a Heterogenous Disease 9:00 am

Reclassifying Alzheimer’s Disease based on Molecular Mechanisms Based on Targets Refining & Subtyping Alzheimer’s Disease to Stratify Patients for Drug Development & Optimize Treatment Utilising imaging & Fluid biomarkers to identify subtypes of Alzheimer’s Disease Utilizing a range of metrics to identify subtypes of Alzheimer’s Disease into different subcomponents. Determining the co-pathology of Alzheimer’s DiseaseRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.